Figure 4
Figure 4. The αGal1 mAb 8F4F8G7 inhibits rGal1-induced apoptosis of in vitro–activated T cells. αCD3/CD28–activated human T cells were treated with 10μM rGal1 alone or 10μM rGal1 preincubated with 5μM αGal1 mAb (8F4F8G7) or an isotype-matched IgG2bλ control, and evaluated thereafter with a flow cytometric apoptosis assay (annexin V–FITC and propidium iodide staining). The percentage of cells in each quadrant is indicated (A). The histogram summarizes the percentage of annexin V+ cells in the absence of rGal1 or in the presence of rGal1 alone or rGal1 preincubated with the αGal1 mAb or the isotype control (B).

The αGal1 mAb 8F4F8G7 inhibits rGal1-induced apoptosis of in vitro–activated T cells. αCD3/CD28–activated human T cells were treated with 10μM rGal1 alone or 10μM rGal1 preincubated with 5μM αGal1 mAb (8F4F8G7) or an isotype-matched IgG2bλ control, and evaluated thereafter with a flow cytometric apoptosis assay (annexin V–FITC and propidium iodide staining). The percentage of cells in each quadrant is indicated (A). The histogram summarizes the percentage of annexin V+ cells in the absence of rGal1 or in the presence of rGal1 alone or rGal1 preincubated with the αGal1 mAb or the isotype control (B).

Close Modal

or Create an Account

Close Modal
Close Modal